Stay updated with breaking news from Inmaculada Hern. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eli Lilly announced it is reducing insulin prices after years of criticism that the price of the lifesaving diabetes medication had become unaffordable. The move, made amid efforts by California and others to introduce low-cost insulin options to the marketplace, may Sanofi and Novo Nordisk – the two other major drugmakers that sell insulin – to lower their prices too.
Drug pricing experts predict the move will help other initiatives to bring lower-cost insulin to market and maintain pressure on Eli Lilly to keep its prices down.
_1b78fec41a5143afb6e7b9ad317023d2-620x480.jpg)
When drugmaker Eli Lilly announced Wednesday it will slash the list price for some of its insulin products following years of criticism from lawmakers and activists that the price of the lifesaving hormone had become unaffordable, the news raised questions about what will happen to other efforts to provide low-cost insulin.
New publication by iDiv member at IPK Leibniz Institute Based on a press release by IPK Leibniz Institute Gatersleben. Genomes differ between the individuals of one species and we can learn a lot about diversity in our crops by comparing genomes of different varieties. However, researchers that want to study many genomes need a fast and reliable method for sequence assembly. An international research team led by the IPK Leibniz Institute has now investigated a new DNA sequencing method. The results, which have now been published in the journal The Plant Cell, are very promising. The scientist...